SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Nieh confirmed for the NRC

November 19, 2025, 3:00PMNuclear News

Earlier today, the U.S. Senate officially confirmed Ho Nieh in a 66–32 vote to serve as a commissioner on the U.S. Nuclear Regulatory Commission through the remainder of a term that will...

New financing round benefits Valar

November 13, 2025, 3:00PMNuclear News

Hawthorne, Calif.–based reactor start-up Valar Atomics recently announced that it has raised $130 million in its Series A funding round, led by venture capital groups Snowpoint, Day One, and...

X-energy begins irradiation testing at INL

November 12, 2025, 3:01PMNuclear News

Advanced reactor and fuel developer X-energy has officially begun confirmatory irradiation testing at Idaho National Laboratory on its TRISO-X fuel. The testing, which is taking place over the...